Segment Reporting (Tables)

3 Months Ended

Mar. 31, 2025

Segment Reporting [Abstract]

Schedule of Operating Expenses by Function

The following table provides information about the Company’s operating expenses by function and includes a reconciliation to net loss.

	Three Months Ended March 31,
	2025			2024
Operating expenses:
Research and development
Clinical	$	5,947		$	7,798
Manufacturing (pre-commercial)		5,447			6,476
Research		5,919			6,344
Other		3,763			4,437
Total Research and development		21,076		$	25,055
General and administrative		6,462			8,707
Total operating expenses		27,538			33,762
Loss from operations		(27,538	)		(33,762	)
Other income, net:
Interest income		635			1,452
Other income, net		39			82
Total other income, net		674			1,534
Net loss before income tax expense		(26,864	)		(32,228	)
Income tax expense		—			—
Net loss	$	(26,864	)	$	(32,228	)